Horizon Therapeutics Public Ltd Co
Begin Phase 2 trial for VIB7734 in systemic lupus erythematosus
Delivered by the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 1 Feb 2021
- Due
- 30 Jun 2021
- Delivered
- June 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“Phase 2 trial for systemic lupus erythematosus (SLE) expected to begin in the first half of 2021.”
What we found
Evidence strength A What the grades mean
The company initiated the Phase 2 randomized, placebo-controlled trial for HZN-7734 (also known as VIB7734) in patients with systemic lupus erythematosus in June 2021, meeting the first-half 2021 deadline.
-
A Horizon Therapeutics Public Ltd Co 8-K filed 2021-08-04
“In June, the first patient was enrolled in a Phase 2 randomized, placebo-controlled trial to evaluate HZN-7734 in patients with moderate to severe active systemic lupus erythematosus (SLE)” ✓ confirmed on the page
-
A Horizon Therapeutics Public Ltd Co 8-K filed 2021-08-04
“Phase 2 randomized, placebo-controlled trial initiated in June 2021 to evaluate HZN-7734 in patients with SLE” ✓ confirmed on the page
Checked 25 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Clinical milestone
- Indicative materiality
- Medium rules
- Action
- Begin
- Deliverable
- Phase 2 trial for systemic lupus erythematosus
- Language
- Expected (“expects”, “plans”)
- In the company’s control
- High
- Specificity
- High
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you Horizon Therapeutics Public Ltd Co? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C492426-022715 · Corrections policy